Skin Cancer

Treatment with tumour-infiltrating lymphocytes for advanced melanoma outperforms ipilimumab

Presented By

Prof. John Haanen, Netherlands Cancer Institute, the Netherlands

Conference

ESMO 2022

16 November, 2022 18:29

Neoadjuvant pembrolizumab outperforms adjuvant pembrolizumab in resectable stage III–IV melanomas

Presented By

Dr Sapna Patel, MD Anderson Cancer Center, TX, USA

Trial

Phase 2, SWOG S1808

Conference

ESMO 2022

16 November, 2022 18:26

Survival-benefit of neoadjuvant T-VEC maintained over 5 years of follow-up

Presented By

Prof. Reinhard Dummer, University of Zürich, Switzerland

Trial

T-VEC

Conference

ESMO 2022

16 November, 2022 18:24

Baseline ctDNA predicts survival in resected stage III–IV melanoma

Presented By

Prof. Georgina Long, University of Sydney, Australia

Trial

Phase 3, CheckMate 915

Conference

ESMO 2022

16 November, 2022 18:21

Markedly lower skin cancer risk in vitiligo patients

Presented By

Dr John Ferguson, St John’s Institute of Dermatology, UK

Conference

EADV 2022

5 November, 2022 10:47

First results on distant metastasis-free survival in stage II melanoma 

Presented By

Prof. Georgina Long, The University of Sydney, Australia

Trial

Phase 3, KEYNOTE-716

Conference

ASCO 2022

5 August, 2022 13:54

Higher response rates for concurrent triple therapy versus sequential therapy in melanoma

Presented By

Prof. Georgina Long, The University of Sydney, Australia

Trial

Phase 2, NeoTrio

Conference

ASCO 2022

5 August, 2022 13:50

Adjunctive reflective confocal microscopy can curb unnecessary excision for suspected melanoma

Journal

JAMA Dermatology

10 June, 2022 20:27

Kids with solid-organ transplants also at risk for keratinocyte carcinoma

Journal

JAMA Dermatology

10 June, 2022 17:27

Olson grade, need for more treatment are markers of increased skin cancer risk in actinic keratoses

Journal

JAMA Dermatology

6 May, 2022 00:55

Adjuvant pembrolizumab may cut recurrence, mortality in stage-II melanoma

Journal

The Lancet

14 April, 2022 18:07

Is melanoma screening by primary care practitioners linked with overdiagnosis?

Journal

JAMA Dermatology

12 April, 2022 23:14

Merkel cell cancers recur more often than other skin cancers, usually within three years

Journal

JAMA Dermatology

3 March, 2022 19:35

For sentinel node-positive melanoma treatment, location matters

Journal

Annals of Surgery

21 February, 2022 18:04

Race, socioeconomic status tied to melanoma survival

Journal

Journal of the American Academy of Dermatology

18 February, 2022 16:28

Therapeutic lymph node dissection may not be needed in melanoma when index node responds

Journal

JAMA Surgery

15 February, 2022 22:42

Radiomic signature may predict survival in pembrolizumab-treated advanced melanoma

Journal

JAMA Oncology

25 January, 2022 23:28

High-fiber diet tied to better immunotherapy response and progression-free survival in melanoma

Journal

Science

3 January, 2022 22:11

Patient-led surveillance safe, feasible after localized melanoma treatment

Journal

JAMA Dermatology

10 December, 2021 22:51

Expanding the toolbox: what is new in melanoma detection?

Presented By

Prof. James Grichnik, University of South Florida, USA

Conference

ICD 2021

2 December, 2021 17:21

Triplet regimen boosts survival in metastatic melanoma, but at a cost

Journal

JAMA Network Open

26 November, 2021 23:33

BioNTech’s skin cancer therapy wins FDA’s fast track designation

19 November, 2021 16:25

Adjuvant immunotherapy reduces risk of disease recurrence in stage II melanoma

Presented By

Dr Jason Luke, UPMC Hillman Cancer Center, PA, USA

Trial

Phase 3, KEYNOTE-716

Conference

ESMO 2021

19 November, 2021 09:30

IFN-γ signature predicts response to immunotherapy

Presented By

Prof. Christian Blank, Netherlands Cancer Institute, the Netherlands

Trial

Phase 1, DONIMI

Conference

ESMO 2021

19 November, 2021 09:30

Updated results of SECOMBIT trial

Presented By

Prof. Paolo Ascierto, Istituto Nazionale Tumori "Fondazione Pascale", Italy

Trial

Phase 2, SECOMBIT

Conference

ESMO 2021

19 November, 2021 09:30

Combining T-VEC and pembrolizumab does not significantly improve survival in advanced, unresectable melanoma

Presented By

Dr Helen Gogas, National and Kapodistrian University of Athens, Greece

Trial

Phase 3, MASTERKEY-265

Conference

ESMO 2021

19 November, 2021 09:30

Durable intracranial responses with nivolumab/ipilimumab

Presented By

Dr Kim Margolin, City of Hope, CA, USA

Trial

Phase 2, CheckMate204

Conference

ESMO 2021

19 November, 2021 09:29

Early ctDNA reduction in metastatic uveal melanoma correlates better with OS than RECIST response

Presented By

Dr Alexander Shoushtari, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 1/2, IMCgp100-202

Conference

ESMO 2021

19 November, 2021 09:09

‘Diligent’ dermatology care needed in organ-transplant recipients

Journal

JAMA Dermatology

22 October, 2021 22:08

Keratinocyte carcinoma incidence and mortality on the rise

Journal

CMAJ

6 October, 2021 22:42

ESMO 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Trial

DESTINY-Breast03, MONALEESA-2, KEYNOTE-716, CASPIAN, CheckMate-649, Impower010

Conference

ESMO 2021

4 October, 2021 09:27

Support for adjuvant pembrolizumab in earlier-stage melanoma

Conference

ESMO 2021 Congress

21 September, 2021 16:18

Nodal classification system improves assessment of cutaneous melanoma mortality risk

Journal

JAMA Surgery

8 September, 2021 18:15

Adoptive cell therapy less effective in pretreated metastatic melanoma

Journal

Clinical Cancer Research

24 August, 2021 16:23

First-in-class gel shows promise for basal-cell carcinoma

Journal

Clinical Cancer Research

13 August, 2021 17:18

Long-term results from ground-breaking melanoma trials

Presented By

Dr Jedd Wolchok (Memorial Sloan Kettering Cancer Center, NY, USA). Prof. Reinhard Dummer (University Hospital Zürich, Switzerland) , Prof. Georgina Long (Melanoma Institute, Australia)

Trial

CheckMate 067, COLUMBUS, ABC

Conference

ASCO 2021

12 August, 2021 23:10

Novel dual checkpoint blockade improves progression-free survival in melanoma

Presented By

Dr Evan Lipson, Johns Hopkins University, MD, USA

Trial

Phase 3, RELATIVITY-047

Conference

ASCO 2021

12 August, 2021 22:14

Neoadjuvant therapy with nivolumab plus relatlimab is safe and effective in patients with stage III melanoma

Presented By

Dr Rodabe Amaria , MD Anderson Cancer Center, TX, USA

Trial

Phase 2

Conference

ASCO 2021

12 August, 2021 12:16

Lifileucel promising against unresponsive malignant melanoma

Journal

Journal of Clinical Oncology

1 June, 2021 18:20

“Encouraging” data on ipilimumab plus anti-PD-1 in metastatic melanoma

Journal

Lancet Oncology

31 May, 2021 16:51

New Bristol Myers immunotherapy combo better than Opdivo alone in melanoma study

19 May, 2021 23:33

Surveillance, education may help to catch melanomas earlier

Journal

Cancer Epidemiology, Biomarkers and Prevention

16 April, 2021 19:01

Novel drug first to improve outcome of metastatic uveal melanoma

Conference

American Association for Cancer Research (AACR) virtual annual meeting 2021

15 April, 2021 19:13

Common blood pressure medications linked to increased skin cancer risk

Journal

CMAJ

12 April, 2021 23:11

Survival after Mohs surgery likely better at academic, high-volume facilities

Journal

JAMA Dermatology

6 April, 2021 22:32

Chronic immune-related adverse events likely common after anti-PD-1 therapy for melanoma

Journal

JAMA Oncology

1 April, 2021 23:34

Larger surgical margins tied to better outcomes in Merkel cell carcinoma

Journal

JAMA Dermatology

1 April, 2021 18:49

ctDNA levels promising for tracking melanoma treatment progress, predicting outcomes

Journal

The Lancet Oncology

22 February, 2021 23:33

Reassuring data on immune checkpoint inhibitors in autoimmune disease

Journal

Annals of Internal Medicine

17 February, 2021 23:57

Fecal microbiota transplant in melanoma patients helps anti-PD-1 therapy work

Journal

Science

11 February, 2021 22:45

Personal neoantigen vaccine prompts lasting response in melanoma patients

Journal

Nature Medicine online

5 February, 2021 17:30

Skin damage from UV light seen in sun-shielded skin

Journal

PLOS Genetics

18 January, 2021 22:53

UV-induced mutations in seemingly normal skin may predict skin cancer

Journal

Science Advances

11 January, 2021 23:28

Metastatic-melanoma immunotherapy may be tied to increase in second cancers

Journal

JAMA Network Open

17 December, 2020 17:34

Adjuvant immune checkpoint inhibition after complete resection

Conference

ESMO 2020

25 November, 2020 14:55

Immuno-combination therapy in metastatic melanoma

Conference

ESMO 2020

25 November, 2020 14:52

Mohs surgery may not boost survival over standard excision of melanomas on trunk, extremities

Journal

JAMA Dermatology

29 October, 2020 17:03

Melanoma patients still at higher risk for new malignancy after successful systemic immunotherapy

Journal

JAMA Dermatology

24 September, 2020 18:11

Five-year follow-up confirms drug combo lowers odds of melanoma recurrence

Journal

New England Journal of Medicine

2 September, 2020 23:00

Adjuvant pembrolizumab: durable RFS for stage III melanoma

Presented By

Prof. Alexander Eggermont, Princess Máxima Centre, NL

Trial

Phase 3, EORTC 1325-MG/KEYNOTE-054

Conference

ASCO 2020

28 August, 2020 15:45

Pembrolizumab plus low-dose ipilimumab well tolerated after progression on PD1 antibody therapy

Principal Investigator

Dr Daniel Olson, The University of Chicago Comprehensive Cancer Center, IL, USA

Trial

Phase 2

Conference

ASCO 2020

28 August, 2020 15:05

Toripalimab plus axitinib effective in metastatic mucosal melanoma

Presented By

Dr Xinan Sheng, Peking University Cancer Hospital and Institute, China

Trial

Phase 1

Conference

ASCO 2020

28 August, 2020 14:13

Pembrolizumab leads to higher toxicity risk in obese melanoma patients

Presented By

Ms Surya Ravichandran, Duke University, USA

Conference

AAD 2020

6 August, 2020 07:03

Can gene expression help to pick the right biologic to treat psoriasis in cancer patients?

Presented By

Dr Nikolai Klebanov , Brigham and Women’s Hospital, USA

Conference

AAD 2020

6 August, 2020 07:01

Long-term data from CheckMate 067

Presented By

Prof. James Larkin, Royal Marsden NHS Foundation Trust, London, UK

Trial

Phase 3, CheckMate 067

Conference

ESMO 2019

26 November, 2019 23:06

Adjuvant nivolumab provides benefit

Presented By

Prof. Jeffrey S. Weber, NYU Langone Medical Center, New York City, USA

Trial

Phase 3, CheckMate 238

Conference

ESMO 2019

26 November, 2019 22:15

Nivolumab+ipilimumab superior to monotherapy for melanoma brain metastases

Presented By

Prof. Georgina Long, Melanoma Institute Australia, Sydney, Australia

Trial

ABC

Conference

ESMO 2019

26 November, 2019 14:15

Above-the-neck melanoma more prone to metastases

Presented By

Dr Mohammed Al Abadie, Cross Hospital; Cannock Chase Hospital, United Kingdom

Conference

EADV 2019

9 October, 2019 20:53

Systemic photoprotection: a valuable addition to topical sun protection

Presented By

Prof. Salvador González Rodriguez, University of Alcala de Henares, Spain

Conference

EADV 2019

9 October, 2019 19:35

The underestimated effect of visible light

Presented By

Dr Serena Lembo, University of Naples Federico II, Italy

Conference

EADV 2019

9 October, 2019 14:38

Will malignant melanoma become a curable disease?

Presented By

Prof. Claus Garbe; Prof. Caroline Robert

Trial

COMBI-d, COMBI-v, COMBI-i, KEYNOTE-001

Conference

WCD 2019

26 August, 2019 20:46

Surgical management of melanoma

Presented By

Prof. John Kelly, The Alfred Hospital, Australia

Conference

WCD 2019

26 August, 2019 11:48

Nivolumab-mediated adverse events are independent of efficacy in resected advanced melanoma

Presented By

Prof. Mario Mandalà, Papa Giovanni XXIII Cancer Centre Hospital, Bergamo, Italy

Trial

CheckMate 238

Conference

ASCO 2019

15 July, 2019 23:18

Long term quality of life with nivolumab, or in combination (ipilimumab) in advanced melanoma

Trial

Phase 3, CheckMate 067

Conference

ASCO 2019

15 July, 2019 12:45

Intralesional 5-fluorouracil induced high clearance rates in cutaneous squamous cell carcinoma

Presented By

Dr Emma Guttman-Yassky, Mount Sinai School of Medicine, USA

Conference

AAD 2019

19 April, 2019 15:20

Melanoma incidence continues to rise in Europe

Presented By

Emily Dando, University of Pittsburgh School of Medicine, USA

Conference

AAD 2018

20 December, 2018 18:15

Lesions in paediatric patients and possible correlation with coffee drinking

Presented By

Dr Ryan Kelm, Feinberg School of Medicine, USA

Conference

AAD 2018

20 December, 2018 17:22

CNNs and targeted combination therapy

Presented By

Dr Allan Halpern, Memorial Sloan Kettering Cancer Center, USA

Conference

AAD 2018

20 December, 2018 15:27